1-(2-morpholin-4-ylethyl)-1H-pyrazol-4-amine dihydrochloride, 95.0%, 250mg

3-(2-AMINO-4-PYRIMIDINYL)BENZENECARBONITRILE, 95.0%, 1g

1-cyclohexanecarbonyl-1,4-diazepane, 95.0%, 2g

ethyl 1-benzyl-5-oxo-2,5-dihydro-1H-pyrazole-3-carboxylate, 98%, 10g

Dimorpholinomethanone, 98.0%, 25g

tert-Butyl 7-azabicyclo[2.2.1]heptan-2-ylcarbamate hydrochloride, 97.0%, 1g

ETHYL N-(TERT-BUTOXYCARBONYL)-N-((1-(HYDROXYMETHYL)CYCLOPROPYL)METHYL)GLYCINATE, 95.0%, 250mg

H-D-Ser-OMe.HCl>98.0%(T)25g

Acetone D6, 99.8 at%D, 25 ml, glass packaging

3-Amino-N-tert-butyl-benzenesulfonamide, 95.0%, 250mg

(3S,4S)-4-(1-piperidinyl)-3-pyrrolidinol dihydrochloride, 95.0%, 1g

4-Bromo-N-methylbutan-1-amine hydrobromide, 95.0%, 100mg

2,2-Dimethyl-4-oxo-3,7,10,13-tetraoxahexadecan-16-oic acid, 95%, 250mg